Health Care & Life Sciences » Pharmaceuticals | Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Oramed Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Micro Cap ETF
27,382
0.16%
0
0.01%
09/06/2018
16,923
0.1%
-1,910
1.44%
06/28/2018
Fidelity Nasdaq Composite Index
5,403
0.03%
0
0%
07/31/2018
5,298
0.03%
-767
0.52%
06/28/2018
2,688
0.02%
447
0.15%
05/31/2018
1,960
0.01%
-36
0.46%
06/28/2018
1,491
0.01%
-402
1.44%
06/28/2018
1,285
0.01%
0
0.06%
09/06/2018

About Oramed Pharmaceuticals

View Profile
Address
Hi-Tech Park 2/4
Jerusalem JM 91390
Israel
Employees -
Website http://www.oramed.com
Updated 07/08/2019
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.